Skip to main content

CORRECTION article

Front. Pharmacol., 07 September 2023
Sec. Ethnopharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1258855

Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial

This article is a correction to:

  1. A Chinese Medicine Formula (Bushen Huoxue Tongluo) for the Treatment of Chronic Subjective Tinnitus: A Study Protocol for a Pilot, Assessor-Blinded, Randomized Clinical Trial

    1. Read original article
Hong Wei Zhang, Hong Wei Zhang1,2*Kammy N. K. YeungKammy N. K. Yeung3Michael C. F. TongMichael C. F. Tong3Zhi-Xiu Lin,Zhi-Xiu Lin1,2Waitsz W. T. ChangWaitsz W. T. Chang3Iris H-Y. NgIris H-Y. Ng3Chi Him SumChi Him Sum2Ka Chun LeungKa Chun Leung2Kam Leung Chan,Kam Leung Chan1,2Kit NganKit Ngan4Tie Jun TongTie Jun Tong5
  • 1Faculty of Medicine, School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
  • 2Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
  • 3Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
  • 4Prime & Naturals Clinic, Hong Kong, Hong Kong SAR, China
  • 5Department of Mathematics, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China

A Corrigendum on
A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial

by Zhang HW, Yeung KNK, Tong MCF, Lin Z-, Chang WWT, Ng IH-, Sum CH, Leung KC, Chan KL, Ngan K and Tong TJ (2022). Front. Pharmacol. 13:844730. doi: 10.3389/fphar. 2022.844730

In the published article, there was an error in the Funding statement. This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 18190691).The correct Funding statement appears below.

“This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 17180941)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Chinese medicine, tinnitus, randomized controlled trial, pilot, clinical trial protocol, herb

Citation: Zhang HW, Yeung KNK, Tong MCF, Lin Z-X, Chang WWT, Ng IH-Y, Sum CH, Leung KC, Chan KL, Ngan K and Tong TJ (2023) Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial. Front. Pharmacol. 14:1258855. doi: 10.3389/fphar.2023.1258855

Received: 14 July 2023; Accepted: 17 July 2023;
Published: 07 September 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Zhang, Yeung, Tong, Lin, Chang, Ng, Sum, Leung, Chan, Ngan and Tong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hong Wei Zhang, zhanghw@cuhk.edu.hk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.